Prostate cancer: Combination of vaccine plus ipilimumab - Safety and toxicity

Nature Reviews Urology

Volumn 9, Issue 6, 2012, Pages 302-303

  Sharma, Padmanee ^a   Logothetis, Christopher ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER VACCINE; CORTICOSTEROID; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR VACCINE; IPILIMUMAB;

ADRENAL INSUFFICIENCY; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER SURVIVAL; CASTRATION RESISTANT PROSTATE CANCER; COLITIS; CORTICOSTEROID INDUCED MYOPATHY; CORTICOSTEROID THERAPY; DIARRHEA; DRUG DOSE ESCALATION; DRUG ERUPTION; DRUG SAFETY; DRUG WITHDRAWAL; HORMONE SUBSTITUTION; HUMAN; HYPERTRANSAMINASEMIA; HYPOTHYROIDISM; KIDNEY CARCINOMA; LUNG NON SMALL CELL CANCER; MELANOMA; METASTATIC MELANOMA; MONOTHERAPY; NEUTROPENIA; NONHUMAN; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; SHORT SURVEY;

ANTIBODIES, MONOCLONAL; CANCER VACCINES; CTLA-4 ANTIGEN; DRUG THERAPY, COMBINATION; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 84862199898     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.103     Document Type: Short Survey

References (7)

1. Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250-1261 (2008).
2. Abdollah, F. et al. Prediction of functional outcomes after nerve-sparing radical prostatectomy: Results of conditional survival analyses. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2012.02.057.
3. Sacco, E. et al. Urinary incontinence after radical prostatectomy: Incidence by definition, risk factors and temporal trend in a large series with a long-term follow-up. BJU Int. 97, 1234-1241 (2006).
4. Wallerstedt, A. et al. Pad use and patient reported bother from urinary leakage after radical prostatectomy. J. Urol. 187, 196-200 (2012).
5. Mulhall, J. P., Parker, M., Waters, B. W. & Flanigan, R. The timing of penile rehabilitation after bilateral nerve-sparing radical prostatectomy affects the recovery of erectile function. BJU Int. 105, 37-41 (2010).
6. Montorsi, F. et al. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur. Urol. 54, 924-931 (2008).
7. Rabbani, F. et al. Time course of recovery of erectile function after radical retropubic prostatectomy: Does anyone recover after 2 years? J. Sex. Med. 7, 3984-3990 (2010).